Insider at RMD plans Rule 144 sale of 2,000 common shares

RMD received a Rule 144 notice indicating that shareholder Peter C Farrell plans to sell 2,000 shares of common stock through Merrill Lynch on or about 01/07/2026 on the NYSE.

Rhea-AI Filing Summary

RMD received a Rule 144 notice indicating that shareholder Peter C Farrell plans to sell 2,000 shares of common stock through Merrill Lynch on or about 01/07/2026 on the NYSE. The filing lists an aggregate market value of $497,580 for the planned sale and notes that 44,448,959 shares of the same class were outstanding.

The 2,000 shares to be sold were acquired on 11/11/2014 via a stock option from Peter C Farrell and paid for in cash. Over the past three months, Peter C Farrell previously sold 2,000 shares on 11/12/2025 for gross proceeds of $504,020 and another 2,000 shares on 12/04/2025 for $502,860. By signing the notice, the seller represents that he does not know of any material adverse information about the issuer’s operations that has not been publicly disclosed.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the latest Form 144 filing for RMD disclose?

The Form 144 discloses that shareholder Peter C Farrell intends to sell 2,000 shares of RMD common stock on or about 01/07/2026 through Merrill Lynch on the NYSE, with a stated aggregate market value of $497,580.

How many RMD shares has Peter C Farrell recently sold or plans to sell?

The notice shows a planned sale of 2,000 shares, and past 3‑month sales of 2,000 shares on 11/12/2025 and 2,000 shares on 12/04/2025, for a total of 6,000 shares including the planned transaction.

When and how were the RMD shares in the Form 144 acquired?

The 2,000 shares covered by the Form 144 were acquired on 11/11/2014 through a stock option transaction from Peter C Farrell, with the purchase price paid in cash on the same date.

What prior sale prices are disclosed in the RMD Form 144 filing?

The filing reports gross proceeds of $504,020 from a sale of 2,000 shares on 11/12/2025 and $502,860 from another sale of 2,000 shares on 12/04/2025.

What does the Form 144 say about undisclosed adverse information for RMD?

By signing the notice, the selling holder represents that he does not know any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed.

How many RMD common shares are outstanding according to this Form 144?

The Form 144 lists 44,448,959 shares of the issuer’s common stock as outstanding for the class of securities involved in the planned sale.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 01/07/2026 - 05:03 PM EST Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001186102
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	ResMed INC
SEC File Number	001-15317
Address of Issuer	9001 Spectrum Center Blvd San Diego CALIFORNIA 92123
Phone	858-746-2400
Name of Person for Whose Account the Securities are To Be Sold	Peter C Farrell
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Merrill Lynch 2049 Century Park East, Ste 1200 Los Angeles CA 90067	2000	497580	44448959	01/07/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	11/11/2014	Stock Option	Peter C Farrell			2000	11/11/2014	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Peter C Farrell 9001 Spectrum Center Blvd San Deigo CA 92123	Common	11/12/2025	2000	504020
Peter C Farrell 9001 Spectrum Center Blvd San Deigo CA 92123	Common	12/04/2025	2000	502860

144: Remarks and Signature

Remarks
Date of Notice	01/07/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	08/12/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Peter C Farrell
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)